Drug lit midterm (exam 1) - EBM Flashcards

1
Q

What is Evidence-Based Medicine?

A

Evidence-based medicine (EBM) is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients.

good but eliminates our knowledge tho…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is EBM?

A

EBM is the integration of best research evidencewith clinical expertiseand patient values.

so this includes our knowledge and what patients care about

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why EBM?

A

Relying on primary knowledge
- Overestimate efficacy
- Underestimate risks

can lead to:
Variation in clinical services
- Inappropriate care
- Lack of care
- Increased costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following best describes evidence-based medicine?

Medical practices are solely based on personal experience and intuition.

The integration of clinical expertise, patient values, and the best available research evidence in decision-making.

Relying exclusively on traditional or alternative medicine without considering scientific studies.

A rigid adherence to standardized treatment protocols regardless of individual patient needs.

Making medical decisions solely based on the latest trends and popular opinions in the healthcare community.

A

The integration of clinical expertise, patient values, and the best available research evidence in decision-making.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sources of Knowledge in Medicine

A

Reference to tradition - what we have always done

Reference to authority- follow the expert

Trial and error- try until something works

Logical reasoning- coming up with idea based on reason

Scientific method- hypothesis experiment more reputable way to get answers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The Problem…

A

Practice continues to rely on sources of knowledge other than scientific method
why? we are afraid of doing something new based on evidence

Gap between new researchfindings and incorporationinto practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Publication to Implementation

A

this is a forest plot

study of aspirin (which was meant to decrease mortality)

shows lots of evidence in 1 table

randomized control trials in 1 publication - meta analysis

shows how evidence has progressed over time

when apsirin became routine practice but was proven unsafe and then changed 10 years later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cochrane Library Logo

A

meta-analysis

studies where smaller studies are combined to see true impact of study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

figure slide 11

A

Rx was still prescribed even tho it was harmful which goes to show that the doctors we not up to date on the literature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Evidence Based Practice

A

Making a conscientious effort to base clinical decisions on research that is most likely to be free from bias, and using interventions most likely to improve how long or well patients live.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

EBM Process

PPCP

A

EBM Process: (cycle)
assess
ask
acquire
appraise
apply

PPCP: (cycle)
collect
assess
plan
supplement
follow up: monitor and evaluate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patient Scenario

JL is a 70-year-old woman with type 2 diabetes mellitus (DM) presenting for a prescription refillfor hydrochlorothiazide (HCTZ).

JL tells you that her doctor suggested switching her blood pressure medication from HCTZ to lisinopril to better protect her kidneys from damage related to type 2 DM since she had an abnormal urine test.

JL is reluctant to make this change because her friend had a “bad reaction” to lisinopril.

She would like to know what you think about her doctor’s suggestion.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Assess

A

Assess patient and/or problem to determine pertinent issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Background Questions

A

Covers the more basic scientific concepts

Does not refer to a particular patient situation

Can be answered using tertiary resources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Foreground Question

A

Covers how these concepts are applied to an individual patient’s circumstance

Must have adequate background knowledge to ask and answer these questions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Think – Pair – Share

A

How would you assess this situation?

What background questions wouldyou ask about the disease stateor medications in question?

mechanism of action
side effects
storage
stability
contraindication

how does DM2 damage kidneys

lisinopril is an ACE inhibitor

how long for DM2 to cause kidney damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Developing a Clinical Question

Four parts to the question (PICO)

The __________ or problem being addressed
The __________ or exposure being considered
The __________ intervention or exposure when relevant
The clinical _________________ of interest

A

The _patient_________ or problem (disease most often) being addressed

The _intervention_________ or exposure being considered

The _comparison _________ intervention or exposure when relevant

The clinical __outcome_______________ of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Think – Pair – Share

What is the PICO question for this scenario?

P:
I:
C:
O:

Question:

A

P: elderly woman with DM2 + HTN
I: lisinopril
C: HCTZ
O: protect kidneys or prevent diabetic nephropathy

Question: is lisinopril better at protecting that kidney than HCTZ in elderly ppl with DM2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Classification of Questions

A

Therapy or prevention
Etiology or harm
Prognosis
Diagnosis
Economic impact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hierarchy of evidence

Evidence-Based Guidelines

A

background info, expert opinion

case report/case series

case control study

cohort study

non-randomzed controlled trials

randomized controlled trials

systematic reviews & meta-analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In which order is it recommended that you search resources?

Primary, secondary, then tertiary
Secondary, primary, then tertiary
Tertiary, primary, then secondary
Primary, tertiary, then secondary
Secondary, tertiary, then primary
Tertiary, secondary, then primary

A

Tertiary, secondary, then primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Types of Biomedical References

A

Primary
Original Research:
Meta-Analysis
clinical trials
Observational Studies
Case Reports/Series

Secondary
Indexing/Abstracting Resources:
PubMed
ovid medline
Scopus

Tertiary
Filtered/Summarized:
Lexicomp
DynaMed
Review Articles

23
Q

Think – Pair – Share

A

What source(s) can you use to answer your background questions?

lexicomp or dynamed then pubmed then meta-analysis

24
Q

Acquire

A

DynaMed

diabetic kidney disease
- ADA recommendations for the management of diabetic kidney disease
– preventative angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs)
— for nonpregnant patients with diabetes and hypertension

either an ACE inhibitor or an ARB is recommended for those with modestly elevated urinary albumin-to-creatinine ratio (30-299 mg/g creatinine)

either an ACE inhibitor or an ARB is strongly recommended for those with a urinary albumin-to-creatinine ratio (> 300 mg/g creatinine and/or estimated GFR < 60 mL/minute/1.73 m^2

ACE inhibitors or ARBs are not recommended for the primary prevention of chronic kidney disease in patients with diabetes who have
- normal blood pressure
- normal urinary albumin-to-creatinine ratio
- normal estimated GFR

25
Q

Identifying search terms from a PICO question

A

Each component (P – I – C – O) can serve as a search term
Generally start with P (diseasestate) and I
Add C if specific to case at hand
Add O if needed to narrow search

26
Q

Identify the search terms from the PICO question Below

A

Is lisinopril better at protecting the kidneys than HCTZ in elderly people with DM2

What term(s) will we start with? - DM2, Lisinopril, HCTZ

What term(s) can help narrow the search? - protecting the kidneys

What term(s) can help us include or eliminate articles? - protecting kidneys, elderly

27
Q

pub med chart

A
28
Q

Appraise

A

valid

applicable

can we apply it to the patient

29
Q

Evaluating validity

A

The “So What?” test

What outcomes were evaluated?

What was the magnitude of the benefit?

The number needed to treat (NNT) / Number needed to harm (NNH)

Relative risk reduction vs. absolute risk reduction

How will this change my practice?

30
Q

Applicability (generalizability)

A

Are the study participants similar to your patients?
- Demographics
- Level of risk

What is the patient’s perspective and preference?
- Values
- Cultural norms
- Costs

31
Q

Types of Evidence

A

Disease-Oriented Evidence (DOE) - does the drug reduce BP or cholesterol, did the drug change a marker for disease

Patient-Oriented Evidence (POE) - what patients care about

32
Q

Patient-Oriented Evidence that Matters (POEMs)

A

Evaluates the effectiveness of interventions that clinicians and patients care about

DOE - Statins down cholesterol

Statins down CV mortality/morbidity

POEM - statins down overal mortality

33
Q

Disease Oriented Evidence (DOE) vs. Patient Oriented Evidence (POE)

A

DOE
Vitamin E is a powerful antioxidant
HRT (down) LDL and (up) HDL
Erythropoietin increases Hgb in patients with cancer

POE
Vitamin E _does not prevent____________ CV disease or cancer
HRT _raises risk of______ stroke and breast cancer
Erythropoietin __increases mortality___________ in cancer patients

34
Q

How do you determine if a study is POEM?

A

1- Does the primary outcome of the study address an outcome patients care about?

2- Is the intervention feasible?

3- Will the information require you to change practice?

		If yes to all 3 = POEM
35
Q

abstract A vs abstract B

A

A - talks about how the epithelial cells work which patients do not care about

B - patients care about not having stroke

36
Q

Which abstract best represents Patient oriented evidence that matters?

Abstract A
Abstract B
Neither
Unsure

A

B is better because it focuses on what the patient cares about

37
Q

appraise

A

can it be applied to the patient?

38
Q

How do we respond to JL?

A

the doctor is right, I don’t know your values but if they are abnormal then lisinopril will help you

39
Q

Influence of PhRMA

A

Levels of interactions

  • Clinicians
  • Researchers
  • Professional organizations
  • Journals
  • Continuing education (CE)
  • Direct-to-consumer advertising
40
Q

How bad is PhRMA’s influence?

A

JNC V (1993) recommendations vs. actual practice

Survey of 35,000 retail pharmacies (62% of US) for 1992 and 1995:

41
Q

PhRMA Influence

A

Most studies have shown that physicians do not believe that interactions with sales representatives impact prescribing

Receipt of a higher number of gifts associated with the belief that there was no impact on prescribing

Drug samples lead to higher brand-name prescriptions

Sponsored lectures/symposia lead to prescribing without sufficient evidence

42
Q

Opioid Crisis

A

Purdue Pharma
- Funded > 20,000 educational programs
- Provided financial support for the American Pain Society
- Salesforce provided doctors with merchandise

they are addicted to drugs now :(

43
Q

Curbing industry influence

A

Code on Interactions with Healthcare -
- Professionals (HCP)
- Developed by PhRMA
- Implemented in 2002, updated in 2009
- Limits on interactions with HCP

Centers for Medicare & Medicaid Services (CMS) Open Payments Database
- System to track physicians that receive payment from a pharmaceutical company

44
Q

Did it work?

A

Comparison of prescribing in US academic medical centers with restrictions on sales representatives vs. those without

Hospitals in 5 states evaluated (CA, IL, MA, PA, NY)

Drugs in 8 classes were evaluated

Analyzed > 1.6 million prescriptions written by > 2000 physicians

Stricter policies led to modest by significant changes in prescribing

45
Q

Advertisements

A

FDA Requirements
- Accurate, truthful, and not misleading
- Reflect balance betweenharms and benefits
- Make claims only supported by appropriate evidence
- Be consistent with FDA-approved labeling

PhRMA Requirements
- Educate patients about treatment options
- Increase awareness about diseases
- Motivate patients to consult their doctors
- Increase the likelihood that patients will receive appropriate care
- Encourage compliance with prescription drug treatment regimens

46
Q

Assessment Question

A

What do you notice in this advertisement?

in the fine print: 1/2 of the patients lived 12 months compared to 9 months

47
Q

procort

A

the transfusion increased survival by 1 day

48
Q

Assessment Question

A

A sales representative tells you that Fosamax reduces the risk of hip fractures by 51%

Is this true?
- yes

49
Q

Information Gathering

A

Balancing your information
PUSH
- Receiving information from various sources on various topics
- Extracting what we think we need for our practice

PULL
- Seeking informationto answer a specificquestion

50
Q

EBM Search Engines

A

Scour primary resources more completely than you could do on your own

Utilize available data to answer questions

Identify a variety of clinical information
- Clinical practice guidelines
- Patient education
- Systematic reviews

51
Q

EBM Tools

A

MCPHS Library
A-Z Databases
- Change “All Subjects” to “Evidence-Based Practice”

Partial list
- DynaMed
- Cochrane Library
- TRIP Database
- EBM Reviews
- Pharmacist’s Letter

52
Q

Adopting a Lifelong Process

A

EBM is a life long learning process
- Founded on problem-based learning
- Converting information needs into focused questions
- Utilizing web-based resources to generate evidence
- Critical appraisal of the facts
- Apply your conclusions to your patients

53
Q
A
54
Q
A